Diabetes in Control speaks with top endocrinologists and other medical professionals to bring you the latest in diabetes news and research. This week, we have a special interview with one of the presenters at the AACE 26th Annual Scientific & Clinical Congress in Austin, Texas. Dr. Weir discusses the pros and cons of SGLT-2 inhibitors in clinical practice.
Dr. Matthew Weir, MD is a professor of medicine and director of Nephrology in the Department of Medicine at the University of Maryland. Dr. Weir’s primary research interests include the use of antihypertensive therapy for the treatment of diabetic nephropathy, hypertensive renal injury in African Americans, cardiovascular disease in patients with chronic kidney disease, and mineralocorticoid receptor antagonism to treat atherosclerosis.
Featured videos include:
Part 1: SGLT2 Drugs and Kidney Disease
Part 3: Early Kidney Disease Detection
or view the complete interview here: Complete Interview